Clinical data | |
---|---|
Routes of administration | Injection |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.004.558 |
Chemical and physical data | |
Formula | C11H8Na4O8P2 |
Molar mass | 422.084 gยทmol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
Kappadione is a vitamin K derivative used for the treatment of side effects of vitamin K antagonists such as warfarin, prophylaxis and treatment of vitamin K deficiency bleeding, and hypoprothrombinemia due to various causes. It was manufactured by Eli Lilly and Company. Chemically, it is menadiol sodium diphosphate. It was approved by the US Food and Drug Administration prior to 1982 and marketed by Lilly. It has since been discontinued and is not available in North America.
References
- ^ DrugBank DB09332 . Accessed 21 April 2021.
- "Kappadione overview, medicine.org". Archived from the original on 2016-03-03. Retrieved 2008-04-14.
This drug article relating to the blood and blood forming organs is a stub. You can help Misplaced Pages by expanding it. |